IMGT®, the international ImMunoGeneTics information system® 25 years on

MP Lefranc, V Giudicelli, P Duroux… - Nucleic acids …, 2015 - academic.oup.com
MP Lefranc, V Giudicelli, P Duroux, J Jabado-Michaloud, G Folch, S Aouinti, E Carillon…
Nucleic acids research, 2015academic.oup.com
IMGT®, the international ImMunoGeneTics information system®(http://www. imgt. org) is the
global reference in immunogenetics and immunoinformatics. By its creation in 1989 by
Marie-Paule Lefranc (Université de Montpellier and CNRS), IMGT® marked the advent of
immunoinformatics, which emerged at the interface between immunogenetics and
bioinformatics. IMGT® is specialized in the immunoglobulins (IG) or antibodies, T cell
receptors (TR), major histocompatibility (MH) and proteins of the IgSF and MhSF …
Abstract
IMGT®, the international ImMunoGeneTics information system®(http://www.imgt.org) is the global reference in immunogenetics and immunoinformatics. By its creation in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS), IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. IMGT® is specialized in the immunoglobulins (IG) or antibodies, T cell receptors (TR), major histocompatibility (MH) and proteins of the IgSF and MhSF superfamilies. IMGT® is built on the IMGT-ONTOLOGY axioms and concepts, which bridged the gap between genes, sequences and 3D structures. The concepts include the IMGT® standardized keywords (identification), IMGT® standardized labels (description), IMGT® standardized nomenclature (classification), IMGT unique numbering and IMGT Colliers de Perles (numerotation). IMGT® comprises 7 databases, 17 online tools and 15 000 pages of web resources, and provides a high-quality and integrated system for analysis of the genomic and expressed IG and TR repertoire of the adaptive immune responses, including NGS high-throughput data. Tools and databases are used in basic, veterinary and medical research, in clinical applications (mutation analysis in leukemia and lymphoma) and in antibody engineering and humanization. The IMGT/mAb-DB interface was developed for therapeutic antibodies and fusion proteins for immunological applications (FPIA). IMGT® is freely available at http://www.imgt.org.
Oxford University Press